J Korean Med Sci.  2010 Jan;25(1):128-134. 10.3346/jkms.2010.25.1.128.

The Anti-Inflammatory Effects of Ulinastatin in Trauma Patients with Hemorrhagic Shock

Affiliations
  • 1Department of Emergency Medicine, Jeju National University Hospital, Jeju, Korea.
  • 2Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. ed119@yonsei.ac.kr

Abstract

We investigated the use of ulinastatin in association with the suppression of polymorphonuclear leukocyte elastase (PMNE), tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), and its effects on the prognosis of patients with traumatic hemorrhagic shock. Nineteen patients who visited the emergency department for traumatic hemorrhagic shock were enrolled. Eleven patients were randomly selected to receive a total of 300,000 IU of ulinastatin. Measurements of serum PMNE, TNF-alpha and IL-6 were taken before ulinastatin treatment at 24 hr, two days, three days, and seven days after admission. We compared the Systemic Inflammatory Response Syndrome scores, Multiple Organ Dysfunction Syndrome scores and Acute Physiology, age, Chronic Health Evaluation III scores of the control and ulinastatin groups. There were no significant differences in baseline values, laboratory data, treatment or mortality between the two groups. The serum PMNE levels in the ulinastatin group were lower than in the control group on the second hospitalized day. Serum TNF-alpha and IL-6 levels in the ulinastatin group decreased 24 hr after admission but had no significance. It is suggested that ulinastatin treatment could decrease the serum PMNE levels in trauma patients with hemorrhagic shock at 48 hr after treatment.

Keyword

Ulinastatin; Shock, Hemorrhagic; Leukocyte Elastase; Tumor Necrosis Factor-alpha; Interleukin-6

MeSH Terms

Adult
Aged
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Female
Glycoproteins/*therapeutic use
Humans
Interleukin-6/blood
Leukocyte Elastase/blood
Male
Middle Aged
Severity of Illness Index
Shock, Hemorrhagic/*drug therapy
Tumor Necrosis Factor-alpha/blood
Anti-Inflammatory Agents, Non-Steroidal
Glycoproteins
Interleukin-6
Tumor Necrosis Factor-alpha
Leukocyte Elastase
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error